Deutsche Bank’s Annovis Bio ANVS Stock Holding History

Deutsche Bank’s Portfolio ANVS Stock Details ANVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,367	Closed	-$374K	–	4389
2021 Q2	$374K	Buy	+4,367	New	+$202K	﹤0.01%	3407

Other funds holding ANVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

WFAG

Wescott Financial Advisory Group Philadelphia, Pennsylvania $1.14B AUM 16.59% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Deutsche Bank's ANVS Position: Q3 2021 in Review

Deutsche Bank sold out of Annovis Bio (ANVS) in Q3 2021, closing a stake of 4,367 shares — an estimated $374K sold.

Deutsche Bank first reported a position in ANVS in Q2 2021 and held it in 1 quarter. The position peaked at $374K in Q2 2021. 38 funds tracked by Wall St. Rank hold ANVS as of Q3 2021.

Deutsche Bank reported no remaining Annovis Bio position as of Q3 2021 after selling out during the quarter.
Deutsche Bank sold 4,367 Annovis Bio shares in Q3 2021, an estimated $374K.
Deutsche Bank first reported a position in Annovis Bio in Q2 2021 and held it in 1 quarter.
Deutsche Bank's Annovis Bio position peaked at $374K in Q2 2021.
38 funds tracked by Wall St. Rank held Annovis Bio as of Q3 2021.

Based on Deutsche Bank's 13F filing for Q3 2021, filed 4 Nov 2021.